NICE provides NATIONAL GUIDANCE and RECOMMENDATIONS for healthcare in the UK.
NICE guidelines are evidence-based recommendations for health and care in England.
They set out the care and services suitable for most people with a specific condition or need, and people in particular circumstances or settings.
Our guidelines help health and social care professionals to:
- prevent ill health
- promote and protect good health
- improve the quality of care and services
- adapt and provide health and social care services.
All our guidance applies to Wales too. You can find out more on the Welsh Government website.
View important dates in the development process and links to all guidelines in development (Excel).
Guideline types
- clinical
- social care
- public health
- medicines practice
- cancer services
- antimicrobial prescribing.
How we develop our guidelines
We work with health and care professionals, people who use services and carers to draft our recommendations. Find out how we choose our topics, draft and publish our guidelines.
Making decisions using our guidelines
Our guidelines can help you make decisions around prescribing medicines, what treatments to recommend and the promotion of safeguarding.
How to get involved
You can help draft our guidelines by registering as a stakeholder or joining a guideline committee.
Shared decision making
Our guidelines support shared decision making between healthcare professionals and those receiving care and treatment.
Maintaining and updating our guideline portfolio
We’re changing how we manage and maintain our guidelines by prioritising which topics we monitor and update.
Interim clinical guideline surveillance process and methods guide 2013
Interim clinical guideline surveillance process and methods guide 2013
Interim process and methods guide for the clinical guideline updates using standing committees pilot programmed 2013
Interim process and methods guide for the clinical guideline updates using standing committees pilot programmed 2013
COVID-19 rapid guideline: managing COVID-19
COVID-19 rapid guideline: managing COVID-19
Early and locally advanced breast cancer: diagnosis and management
Early and locally advanced breast cancer: diagnosis and management
Cardiovascular disease: risk assessment and reduction, including lipid modification
Cardiovascular disease: risk assessment and reduction, including lipid modification
Caesarean birth
Caesarean birth
Hypertension in pregnancy: diagnosis and management
Hypertension in pregnancy: diagnosis and management
Lung cancer: diagnosis and management
Lung cancer: diagnosis and management
Barrett’s oesophagus and stage 1 oesophageal adenocarcinoma: monitoring and management
Barrett’s oesophagus and stage 1 oesophageal adenocarcinoma: monitoring and management
Delirium: prevention, diagnosis and management in hospital and long-term care
Delirium: prevention, diagnosis and management in hospital and long-term care
Tobacco: preventing uptake, promoting quitting and treating dependence
Tobacco: preventing uptake, promoting quitting and treating dependence
Disabled children and young people up to 25 with severe complex needs: integrated service delivery and organisation across health, social care and education
Disabled children and young people up to 25 with severe complex needs: integrated service delivery and organisation across health, social care and education
Hip fracture: management
Hip fracture: management
Guideline
2024
CYP2C19 genotype testing to guide clopidogrel use after ischaemic stroke or transient ischaemic attack (New)
In development [GID-DG10054]Expected publication date: 31 July 2024
Asthma: diagnosis, monitoring and chronic asthma management (New)
In development [GID-NG10186] Expected publication date: 27 November 2024
Pembrolizumab plus chemotherapy with or without bevacizumab for persistent, recurrent or metastatic cervical cancer (New)
Published: 13 December 2023
Minimally invasive percutaneous surgical techniques with internal fixation for correcting hallux valgus (New)
Interventional procedures guidance [IPG789] Published: 20 June 2024
Tafamidis for treating transthyretin amyloidosis with cardiomyopathy (New)
Technology appraisal guidance Reference number:TA984 Published: 19 June 2024
Ovarian cancer: identifying and managing familial and genetic risk (New)
NICE guideline [NG241] Published: 21 March 2024
2023
Removal, preservation and reimplantation of ovarian tissue for restoring fertility after gonadotoxic treatment
Interventional procedures guidance [IPG772] Published: 21 September 2023
Endometriosis: diagnosis and management
NICE guideline [NG73] Published: 06 September 2017 Last updated: 16 April 2024
Proov Confirm for ovulation confirmation
Medtech innovation briefing [MIB322] Published: 06 June 2023
Intrapartum care
NICE guideline [NG235] Published: 29 September 2023